Follow
In Young Hwang
In Young Hwang
Verified email at singaporetech.edu.sg
Title
Cited by
Cited by
Year
Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models
IY Hwang, E Koh, A Wong, JC March, WE Bentley, YS Lee, MW Chang
Nature communications 8 (1), 15028, 2017
3772017
Reprogramming microbes to be pathogen-seeking killers
IY Hwang, MH Tan, E Koh, CL Ho, CL Poh, MW Chang
ACS synthetic biology 3 (4), 228-237, 2014
2002014
Tweak to treat: reprograming bacteria for cancer treatment
BFL Sieow, KS Wun, WP Yong, IY Hwang, MW Chang
Trends in cancer 7 (5), 447-464, 2021
872021
Engineering probiotics for therapeutic applications: recent examples and translational outlook
N Aggarwal, AME Breedon, CM Davis, IY Hwang, MW Chang
Current opinion in biotechnology 65, 171-179, 2020
832020
Microbiome and human health: current understanding, engineering, and enabling technologies
N Aggarwal, S Kitano, GRY Puah, S Kittelmann, IY Hwang, MW Chang
Chemical reviews 123 (1), 31-72, 2022
782022
Reprogramming Probiotic Lactobacillus reuteri as a Biosensor for Staphylococcus aureus Derived AIP-I Detection
D Lubkowicz, CL Ho, IY Hwang, WS Yew, YS Lee, MW Chang
ACS synthetic biology 7 (5), 1229-1237, 2018
692018
Reprogrammable microbial cell-based therapeutics against antibiotic-resistant bacteria
IY Hwang, E Koh, HR Kim, WS Yew, MW Chang
Drug Resistance Updates 27, 59-71, 2016
452016
Targeted approaches for in situ gut microbiome manipulation
HL Lee, H Shen, IY Hwang, H Ling, WS Yew, YS Lee, MW Chang
Genes 9 (7), 351, 2018
412018
Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism
E Koh, IY Hwang, HL Lee, R De Sotto, JWJ Lee, YS Lee, JC March, ...
Nature Communications 13 (1), 3834, 2022
372022
Engineering commensal bacteria to rewire host–microbiome interactions
IY Hwang, MW Chang
Current opinion in biotechnology 62, 116-122, 2020
352020
Engineering microbes for targeted strikes against human pathogens
IY Hwang, HL Lee, JG Huang, YY Lim, WS Yew, YS Lee, MW Chang
Cellular and molecular life sciences 75, 2719-2733, 2018
222018
Engineered microbial systems for advanced drug delivery
H Shen, N Aggarwal, KS Wun, YS Lee, IY Hwang, MW Chang
Advanced Drug Delivery Reviews 187, 114364, 2022
192022
Biotherapeutic approaches in atopic dermatitis
EH Tham, E Koh, JEA Common, IY Hwang
Biotechnology Journal 15 (10), 1900322, 2020
192020
Therapeutic reactivation of mutant p53 protein by quinazoline derivatives
HS Sutherland, IY Hwang, ES Marshall, BS Lindsay, WA Denny, ...
Investigational new drugs 30, 2035-2045, 2012
182012
Designing a synthetic genetic circuit that enables cell density-dependent auto-regulatory lysis for macromolecule release
TM Lo, MH Tan, IY Hwang, MW Chang
Chemical engineering science 103, 29-35, 2013
142013
Development of a proline-based selection system for reliable genetic engineering in Chinese hamster ovary cells
T Sun, WC Kwok, KJ Chua, TM Lo, J Potter, WS Yew, JD Chesnut, ...
ACS Synthetic Biology 9 (7), 1864-1872, 2020
112020
Matrix-immobilized yeast for large-scale production of recombinant human lactoferrin
CL Ho, IY Hwang, K Loh, MW Chang
MedChemComm 6 (3), 486-491, 2015
112015
Isolated nucleotide molecule and method of sensing and killing of pathogenic microorganism
MW Chang, IY Hwang, MH Tan, E Koh
US Patent 9,603,877, 2017
82017
Engineered probiotics modulate the endocannabinoid system
IY Hwang, HR Kim, R De Sotto, MW Chang
Biotechnology Notes 2, 33-38, 2021
72021
Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models. Nat Commun. 2017; 8: 15028
IY Hwang, E Koh, A Wong, JC March, WE Bentley, YS Lee, MW Chang
Nat Chem Biol 12 (2), 82-6, 2016
62016
The system can't perform the operation now. Try again later.
Articles 1–20